EU Legislation and Notices - February 23, 2026
Summary
The EU published several legislative acts and decisions on February 23, 2026. These include implementing regulations concerning restrictive measures in Russia, amendments to active substance approvals for biocidal products, and a decision on Iceland's participation in the Union Space Programme.
What changed
The European Union has published several legislative acts and decisions effective February 23, 2026. Key among these are Council Implementing Regulation (EU) 2026/431 and Council Decision (CFSP) 2026/432, which implement and amend restrictive measures concerning the situation in Russia. Additionally, Commission Implementing Regulations (EU) 2026/372, 2026/373, and 2026/385 amend existing regulations regarding the approval of active substances for biocidal products, including formaldehyde-based substances and extending approval periods for various chemicals. Council Decision (EU) 2026/434 also details Iceland's participation in the GOVSATCOM component of the Union Space Programme.
These publications introduce or modify existing regulatory obligations for entities operating within or trading with the EU. Companies involved in sectors affected by sanctions against Russia must ensure compliance with the updated restrictive measures. Manufacturers and formulators of biocidal products need to verify the status of active substances and ensure their products align with the amended approvals and product-type specifications. Businesses participating in or utilizing the EU Space Programme should review the terms of Iceland's participation. Compliance with these regulations is mandatory, and non-adherence could result in penalties as stipulated by relevant EU law.
What to do next
- Review Council Implementing Regulation (EU) 2026/431 and Council Decision (CFSP) 2026/432 for updated restrictive measures concerning Russia.
- Verify compliance of biocidal products with Commission Implementing Regulations (EU) 2026/372, 2026/373, and 2026/385 regarding approved active substances.
- Consult Council Decision (EU) 2026/434 for details on Iceland's participation in the Union Space Programme if applicable.
Source document (simplified)
EUR-Lex Access to European Union law This document is an excerpt from the EUR-Lex website
- EUROPA
- EUR-Lex home
- Official Journal
- Official Journal L series daily view
Menu Search tips Need more search options? Use the Advanced search
- Help
- Export PDF
Official Journal L series daily view
23 February 2026 en Expand all Collapse all OJ structure OJ number publishing time
- Ascending
- Descending
II Non-legislative acts International agreements Council 2026/434 Council Decision (EU) 2026/434 of 17 February 2026 on the signing of the Agreement between the European Union and Iceland laying down the rules for participation of Iceland in the GOVSATCOM component of the Union Space Programme and in the Union Secure Connectivity Programme, and for access to GOVSATCOM services and to the governmental services of the Union Secure Connectivity Programme Regulations Implementing Regulation of the Council 2026/431 Council Implementing Regulation (EU) 2026/431 of 23 February 2026 implementing Regulation (EU) 2024/1485 concerning restrictive measures in view of the situation in Russia Implementing Regulation of the Commission 2026/372 Commission Implementing Regulation (EU) 2026/372 of 20 February 2026 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 1-naphthylacetamide, 1-naphthylacetic acid, 6-benzyladenine, aluminium sulfate, boscalid, dodine, esfenvalerate, eugenol, fenpyroximate, fluazifop-P, fluazinam, fluometuron, fluopyram, flutolanil, geraniol, malathion, penoxsulam, pinoxaden, prohexadione, proquinazid, prosulfuron, pyrethrins, pyridaben, pyrimethanil, sintofen, spiroxamine, sulphur and thymol 2026/373 Commission Implementing Regulation (EU) 2026/373 of 20 February 2026 approving formaldehyde released from the reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 1:1) as an existing active substance for use in biocidal products of product-types 2, 11 and 13 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council 2026/385 Commission Implementing Regulation (EU) 2026/385 of 20 February 2026 approving formaldehyde released from the reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 3:2) as an existing active substance for use in biocidal products of product-types 2, 6, 11, 12 and 13 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council 2026/386 Commission Implementing Regulation (EU) 2026/386 of 20 February 2026 authorising the placing on the market of defatted rapeseed powder as a novel food and amending Implementing Regulation (EU) 2017/2470 Decisions Council Decision based directly on the Treaties 2026/432 Council Decision (CFSP) 2026/432 of 23 February 2026 amending Decision (CFSP) 2024/1484 concerning restrictive measures in view of the situation in Russia 2026/433 Council Decision (EU) 2026/433 of 17 February 2026 appointing an alternate member, proposed by the Kingdom of Sweden, of the Committee of the Regions 2026/438 Council Decision (CFSP) 2026/438 of 23 February 2026 amending Decision (CFSP) 2022/266 concerning restrictive measures in response to the illegal recognition, occupation or annexation by the Russian Federation of certain non-government controlled areas of Ukraine Implementing Decision of the Commission 2026/375 Commission Implementing Decision (EU) 2026/375 of 20 February 2026 on harmonised standards drafted in support of Regulation (EC) No 765/2008 of the European Parliament and of the Council setting out the requirements for accreditation 2026/377 Commission Implementing Decision (EU) 2026/377 of 20 February 2026 postponing the expiry date of the approval of Bacillus sphaericus 2362 serotype H5a5b, strain ABTS1743 for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council 2026/378 Commission Implementing Decision (EU) 2026/378 of 20 February 2026 not renewing the approval of etofenprox for use in biocidal products of product-types 8 and 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council 2026/379 Commission Implementing Decision (EU) 2026/379 of 20 February 2026 repealing Implementing Decisions (EU) 2022/1487 and (EU) 2025/434 postponing the expiry dates of the approval of etofenprox for use in biocidal products of product-types 8 and 18, respectively, in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council 2026/380 Commission Implementing Decision (EU) 2026/380 of 20 February 2026 postponing the expiry date of the approval of propan-2-ol for use in biocidal products of product-types 1, 2 and 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council 2026/381 Commission Implementing Decision (EU) 2026/381 of 20 February 2026 postponing the expiry date of the approval of tebuconazole for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council Corrigenda 2026/90145 The corrigendum does not concern the English version. 2026/90148 The corrigendum does not concern the English version. 2026/90149 The corrigendum does not concern the English version. 2026/90150 The corrigendum does not concern the English version. 2026/90153 The corrigendum does not concern the English version.
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Legislation alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when EUR-Lex Official Journal publishes new changes.